Hemideina has raised funds via a private placement
Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.
Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.
Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.
Elizabeth Williams
CEO and co-founder, Hemideina
Sprechen Sie mit dem Deal-Team
Relevante Transaktionen
Sun European Partners has secured financing to support its acquisition of B&H Worldwide
Sun European Partners has raised debt facilities to support its acquisition of B&H Worldwide.
Weitere InformationenParcom has sold Krifon to Varro
Krifon AS, a leading Nordic B2B distributor specializing in home and garden products, has been acquired by Varro. The transaction marks a new chapter for the company as it continues to strengthen its position as a trusted category partner to leading DIY chains, garden centers and furniture retailers in Norway.
Weitere InformationenEbidco has finalized a voluntary public tender offer for the shares of Eles Semiconductor Equipment
Ebidco S.r.l. has completed a voluntary public tender offer for the shares of Eles Semiconductor Equipment S.p.A.
Weitere Informationen